Breaking News Instant updates and real-time market news.

PFS

Provident Financial

$14.05 /

+0.51 (+3.77%)

13:41
11/05/20
11/05
13:41
11/05/20
13:41

Provident Financial price target raised to 395 GBp from 390 GBp at Barclays

Barclays analyst Michael Sanderson raised the firm's price target on Provident Financial to 395 GBp from 390 GBp and keeps an Overweight rating on the shares.

PFS Provident Financial
$14.05 /

+0.51 (+3.77%)

10/08/20 Janney Montgomery Scott
Provident Financial initiated with a Neutral at Janney Montgomery Scott
03/13/20 Boenning & Scattergood
Provident upgraded to Outperform from Neutral at Boenning & Scattergood
03/13/20 Boenning & Scattergood
SB One Bancorp downgraded to Neutral from Outperform at Boenning & Scattergood

TODAY'S FREE FLY STORIES

Recommendations
Benefitfocus did not bid on South Carolina contract, says Raymond James » 22:21
01/25/21
01/25
22:21
01/25/21
22:21
BNFT

Benefitfocus

$13.90 /

-0.13 (-0.93%)

Raymond James analyst…

Raymond James analyst Brian Peterson corrects his prior research note earlier today that called South Carolina's award for statewide benefits administration system contract to Morneau Shepell a "missed opportunity" for Benefitfocus. The analyst states that after speaking with the company, he learned that Benefitfocus did not bid on the opportunity as the RFP called for a perpetual software license - a model which the company does not offer. Peterson still keeps his Market Perform on Benefitfocus shares.

ShowHide Related Items >><<
BNFT Benefitfocus
$13.90 /

-0.13 (-0.93%)

BNFT Benefitfocus
$13.90 /

-0.13 (-0.93%)

01/25/21 Raymond James
South Carolina award 'a lost opportunity' for Benefitfocus, says Raymond James
01/21/21 Raymond James
Benefitfocus downgraded at Raymond James on 'aggressive' consensus estimates
01/21/21 Raymond James
Benefitfocus downgraded to Market Perform from Outperform at Raymond James
11/06/20 Cantor Fitzgerald
Benefitfocus downgraded to Neutral from Overweight at Cantor Fitzgerald
BNFT Benefitfocus
$13.90 /

-0.13 (-0.93%)

Earnings
Equity Lifestyle sees FY21 FFO $2.26-2.36 , two estimates $2.35 » 20:40
01/25/21
01/25
20:40
01/25/21
20:40
ELS

Equity Lifestyle

$63.78 /

+0.395 (+0.62%)

Sees 2021 core MH rate…

Sees 2021 core MH rate growth of 4.2% and core RV Annual rate growth of 4.5%.

ShowHide Related Items >><<
ELS Equity Lifestyle
$63.78 /

+0.395 (+0.62%)

01/19/21 Baird
Equity Lifestyle reinstated with an Outperform at Baird
01/11/21 BMO Capital
Equity Lifestyle downgraded to Market Perform from Outperform at BMO Capital
12/15/20 Citi
Equity Lifestyle upgraded to Buy from Neutral at Citi
10/01/20 BMO Capital
Sun Communities price target raised to $165 from $160 at BMO Capital
ELS Equity Lifestyle
$63.78 /

+0.395 (+0.62%)

ELS Equity Lifestyle
$63.78 /

+0.395 (+0.62%)

Earnings
Equity Lifestyle reports Q4 FFO 57c, two estimates 56c » 20:38
01/25/21
01/25
20:38
01/25/21
20:38
ELS

Equity Lifestyle

$63.78 /

+0.395 (+0.62%)

Reports Q4 property…

Reports Q4 property operating revenue $261.9M vs. $248.7M last year

ShowHide Related Items >><<
ELS Equity Lifestyle
$63.78 /

+0.395 (+0.62%)

01/19/21 Baird
Equity Lifestyle reinstated with an Outperform at Baird
01/11/21 BMO Capital
Equity Lifestyle downgraded to Market Perform from Outperform at BMO Capital
12/15/20 Citi
Equity Lifestyle upgraded to Buy from Neutral at Citi
10/01/20 BMO Capital
Sun Communities price target raised to $165 from $160 at BMO Capital
ELS Equity Lifestyle
$63.78 /

+0.395 (+0.62%)

ELS Equity Lifestyle
$63.78 /

+0.395 (+0.62%)

Syndicate
Surgalign files to sell 25M shares of common stock » 20:25
01/25/21
01/25
20:25
01/25/21
20:25
SRGA

Surgalign

$2.10 /

+0.03 (+1.45%)

Active bookrunners…

Active bookrunners include Piper Sandler and Cantor Fitzgerald. Lead manager is BTIG. Co-managers include Craig-Hallum and Lake Street.

ShowHide Related Items >><<
SRGA Surgalign
$2.10 /

+0.03 (+1.45%)

SRGA Surgalign
$2.10 /

+0.03 (+1.45%)

11/30/20
Fly Intel: Top five analyst initiations
11/30/20 Lake Street
Surgalign initiated with a Buy at Lake Street
SRGA Surgalign
$2.10 /

+0.03 (+1.45%)

  • 28
    Jan
Earnings
Notable companies reporting before tomorrow's open » 20:25
01/25/21
01/25
20:25
01/25/21
20:25
JNJ

Johnson & Johnson

$165.91 /

+2.23 (+1.36%)

, VZ

Verizon

$58.42 /

+0.95 (+1.65%)

, RTX

Raytheon Technologies

$66.30 /

-1.32 (-1.95%)

, AXP

American Express

$121.19 /

-4.92 (-3.90%)

, MMM

3M

$170.50 /

+1.47 (+0.87%)

, GE

General Electric

$11.00 /

-0.125 (-1.12%)

, LMT

Lockheed Martin

$343.49 /

+2.81 (+0.82%)

, FCX

Freeport McMoRan

$28.96 /

-1.52 (-4.99%)

, ROK

Rockwell Automation

$260.62 /

-5.29 (-1.99%)

, ADM

Archer Daniels

$53.10 /

+0.24 (+0.45%)

, DHI

D.R. Horton

$79.00 /

+1.24 (+1.59%)

, PII

Polaris

$119.51 /

+1 (+0.84%)

, ALK

Alaska Air

$52.83 /

-1.67 (-3.06%)

Notable companies…

Notable companies reporting before tomorrow's open, with earnings consensus, include Johnson & Johnson (JNJ), consensus $1.82... Verizon (VZ), consensus $1.17... Raytheon Technologies (RTX), consensus 70c... American Express (AXP), consensus $1.31... 3M Company (MMM), consensus $2.15... General Electric (GE), consensus 9c... Lockheed Martin (LMT), consensus $6.41... Freeport-McMoRan (FCX), consensus 38c... Rockwell Automation (ROK), consensus $1.89... Archer-Daniels-Midland (ADM), consensus $1.10... D.R. Horton (DHI), consensus $1.68... Polaris (PII), consensus $2.90... Alaska Air (ALK), consensus ($2.87).

ShowHide Related Items >><<
VZ Verizon
$58.42 /

+0.95 (+1.65%)

RTX Raytheon Technologies
$66.30 /

-1.32 (-1.95%)

ROK Rockwell Automation
$260.62 /

-5.29 (-1.99%)

PII Polaris
$119.51 /

+1 (+0.84%)

MMM 3M
$170.50 /

+1.47 (+0.87%)

LMT Lockheed Martin
$343.49 /

+2.81 (+0.82%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

GE General Electric
$11.00 /

-0.125 (-1.12%)

FCX Freeport McMoRan
$28.96 /

-1.52 (-4.99%)

DHI D.R. Horton
$79.00 /

+1.24 (+1.59%)

AXP American Express
$121.19 /

-4.92 (-3.90%)

ALK Alaska Air
$52.83 /

-1.67 (-3.06%)

ADM Archer Daniels
$53.10 /

+0.24 (+0.45%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

01/15/21 B. Riley Securities
Arcturus Therapeutics downgraded to Neutral from Buy at B. Riley Securities
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
01/14/21 Oppenheimer
Essa Pharma price target raised to $20 from $9 at Oppenheimer
12/29/20 Piper Sandler
Piper still believes in Arcturus vaccine after 'underwhelming' immunogenicity
VZ Verizon
$58.42 /

+0.95 (+1.65%)

12/02/20
Fly Intel: Top five analyst upgrades
12/02/20 MoffettNathanson
Verizon upgraded to Buy from Neutral at MoffettNathanson
12/02/20 MoffettNathanson
Verizon upgraded to Buy from Neutral at MoffettNathanson
11/16/20 Wells Fargo
Verizon resumed with an Equal Weight at Wells Fargo
RTX Raytheon Technologies
$66.30 /

-1.32 (-1.95%)

12/21/20 Canaccord
Boeing not in position to challenge Aerojet bid, says Canaccord
12/21/20 RBC Capital
Aerojet Rocketdyne price target raised to $56 from $51 at RBC Capital
12/17/20 DZ Bank
Raytheon Technologies upgraded to Buy from Hold at DZ Bank
12/15/20 JPMorgan
Raytheon Technologies price target raised to $85 from $79 at JPMorgan
AXP American Express
$121.19 /

-4.92 (-3.90%)

01/19/21
Fly Intel: Top five analyst upgrades
01/19/21 JPMorgan
American Express upgraded to Overweight from Underweight at JPMorgan
01/12/21 Susquehanna
American Express price target raised to $124 from $110 at Susquehanna
01/07/21 Wells Fargo
American Express selloff on WSJ story overdone, says Wells Fargo
MMM 3M
$170.50 /

+1.47 (+0.87%)

01/13/21 Deutsche Bank
3M named 'Catalyst Call: Buy Idea' at Deutsche Bank
01/07/21 BofA
3M downgraded to Underperform from Neutral at BofA
10/07/20
Fly Intel: Top five analyst upgrades
10/07/20 JPMorgan
3M price target raised to $170 from $159 at JPMorgan
GE General Electric
$11.00 /

-0.125 (-1.12%)

01/07/21 JPMorgan
GE shares 'de-coupled from long term fundamentals,' says JPMorgan
12/16/20 DZ Bank
General Electric upgraded to Hold from Sell at DZ Bank
12/10/20 Gordon Haskett
SEC settlement clears path for GE to issue shares, says Gordon Haskett
12/10/20 Argus
General Electric price target raised to $14 from $10 at Argus
LMT Lockheed Martin
$343.49 /

+2.81 (+0.82%)

01/07/21 Baird
Lockheed Martin downgraded to Neutral from Outperform at Baird
01/07/21 Jefferies
Jefferies downgrades Aerojet Rocketdyne to Hold, sees higher bid as unlikely
12/22/20 Credit Suisse
Lockheed Martin price target raised to $409 from $400 at Credit Suisse
12/22/20 Truist
Aerojet Rocketdyne downgraded to Hold from Buy at Truist
FCX Freeport McMoRan
$28.96 /

-1.52 (-4.99%)

01/20/21 B. Riley Securities
Freeport McMoRan price target raised to $32 from $30 at B. Riley Securities
01/13/21 Deutsche Bank
Freeport McMoRan price target raised to $33 from $20 at Deutsche Bank
01/05/21
Fly Intel: Top five analyst upgrades
01/05/21 B. Riley Securities
Freeport McMoRan price target raised to $30 from $26 at B. Riley Securities
ROK Rockwell Automation
$260.62 /

-5.29 (-1.99%)

01/04/21 Vertical Research
Rockwell Automation upgraded to Hold from Sell at Vertical Research
11/30/20 Barclays
Rockwell Automation downgraded to Equal Weight on valuation at Barclays
11/30/20 Barclays
Rockwell Automation downgraded to Equal Weight from Overweight at Barclays
11/23/20
Fly Intel: Top five analyst upgrades
ADM Archer Daniels
$53.10 /

+0.24 (+0.45%)

01/20/21 Credit Suisse
Archer Daniels price target raised to $54 from $46 at Credit Suisse
01/11/21 BMO Capital
Archer Daniels downgraded to Market Perform from Outperform at BMO Capital
12/21/20 Barclays
Bunge price target raised to $70 from $65 at Barclays
11/09/20 Barclays
Archer Daniels price target raised to $55 from $52 at Barclays
DHI D.R. Horton
$79.00 /

+1.24 (+1.59%)

01/21/21 Janney Montgomery Scott
Meritage Homes initiated with a Neutral at Janney Montgomery Scott
01/21/21 Janney Montgomery Scott
D.R. Horton initiated with a Neutral at Janney Montgomery Scott
01/08/21 RBC Capital
D.R. Horton upgraded to Outperform from Sector Perform at RBC Capital
01/08/21 RBC Capital
D.R. Horton upgraded to Outperform from Sector Perform at RBC Capital
PII Polaris
$119.51 /

+1 (+0.84%)

01/20/21
Fly Intel: Top five analyst initiations
01/20/21 Morgan Stanley
Morgan Stanley starts Polaris at Overweight with $140 price target
01/20/21 BMO Capital
Polaris upgraded to Outperform from Market Perform at BMO Capital
01/19/21 Morgan Stanley
Polaris initiated with an Overweight at Morgan Stanley
ALK Alaska Air
$52.83 /

-1.67 (-3.06%)

01/14/21 Susquehanna
Alaska Air price target raised to $60 from $50 at Susquehanna
01/14/21 Susquehanna
Susquehanna cuts Delta to Neutral on international and business travel risks
12/11/20 UBS
Alaska Air upgraded to Buy from Neutral at UBS
12/11/20 Deutsche Bank
Alaska Air downgraded to Hold from Buy at Deutsche Bank
VZ Verizon
$58.42 /

+0.95 (+1.65%)

RTX Raytheon Technologies
$66.30 /

-1.32 (-1.95%)

ROK Rockwell Automation
$260.62 /

-5.29 (-1.99%)

PII Polaris
$119.51 /

+1 (+0.84%)

MMM 3M
$170.50 /

+1.47 (+0.87%)

LMT Lockheed Martin
$343.49 /

+2.81 (+0.82%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

GE General Electric
$11.00 /

-0.125 (-1.12%)

FCX Freeport McMoRan
$28.96 /

-1.52 (-4.99%)

DHI D.R. Horton
$79.00 /

+1.24 (+1.59%)

AXP American Express
$121.19 /

-4.92 (-3.90%)

ALK Alaska Air
$52.83 /

-1.67 (-3.06%)

ADM Archer Daniels
$53.10 /

+0.24 (+0.45%)

VZ Verizon
$58.42 /

+0.95 (+1.65%)

RTX Raytheon Technologies
$66.30 /

-1.32 (-1.95%)

MMM 3M
$170.50 /

+1.47 (+0.87%)

LMT Lockheed Martin
$343.49 /

+2.81 (+0.82%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

GE General Electric
$11.00 /

-0.125 (-1.12%)

FCX Freeport McMoRan
$28.96 /

-1.52 (-4.99%)

DHI D.R. Horton
$79.00 /

+1.24 (+1.59%)

AXP American Express
$121.19 /

-4.92 (-3.90%)

ALK Alaska Air
$52.83 /

-1.67 (-3.06%)

ADM Archer Daniels
$53.10 /

+0.24 (+0.45%)

VZ Verizon
$58.42 /

+0.95 (+1.65%)

RTX Raytheon Technologies
$66.30 /

-1.32 (-1.95%)

PII Polaris
$119.51 /

+1 (+0.84%)

MMM 3M
$170.50 /

+1.47 (+0.87%)

LMT Lockheed Martin
$343.49 /

+2.81 (+0.82%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

GE General Electric
$11.00 /

-0.125 (-1.12%)

FCX Freeport McMoRan
$28.96 /

-1.52 (-4.99%)

DHI D.R. Horton
$79.00 /

+1.24 (+1.59%)

AXP American Express
$121.19 /

-4.92 (-3.90%)

ALK Alaska Air
$52.83 /

-1.67 (-3.06%)

ADM Archer Daniels
$53.10 /

+0.24 (+0.45%)

VZ Verizon
$58.42 /

+0.95 (+1.65%)

RTX Raytheon Technologies
$66.30 /

-1.32 (-1.95%)

MMM 3M
$170.50 /

+1.47 (+0.87%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

GE General Electric
$11.00 /

-0.125 (-1.12%)

FCX Freeport McMoRan
$28.96 /

-1.52 (-4.99%)

DHI D.R. Horton
$79.00 /

+1.24 (+1.59%)

AXP American Express
$121.19 /

-4.92 (-3.90%)

ALK Alaska Air
$52.83 /

-1.67 (-3.06%)

ADM Archer Daniels
$53.10 /

+0.24 (+0.45%)

Hot Stocks
Zynga CEO sells 120.8K shares of common stock » 20:03
01/25/21
01/25
20:03
01/25/21
20:03
ZNGA

Zynga

$10.33 /

-0.39 (-3.64%)

In a regulatory filing,…

In a regulatory filing, Zynga disclosed that its CEO Frank Gibeau sold 120.8K shares of common stock on January 21st in a total transaction size of $1.33M, reducing his stake by about 5%.

ShowHide Related Items >><<
ZNGA Zynga
$10.33 /

-0.39 (-3.64%)

ZNGA Zynga
$10.33 /

-0.39 (-3.64%)

12/22/20 Morgan Stanley
Zynga price target raised to $12 from $11 at Morgan Stanley
12/16/20
Fly Intel: Top five analyst upgrades
12/16/20 JPMorgan
Zynga upgraded to Overweight from Neutral at JPMorgan
12/15/20 Wells Fargo
Zynga upgraded to Overweight after 'overdone' post-Q3 pullback at Wells Fargo
ZNGA Zynga
$10.33 /

-0.39 (-3.64%)

  • 07
    Aug
ZNGA Zynga
$10.33 /

-0.39 (-3.64%)

ZNGA Zynga
$10.33 /

-0.39 (-3.64%)

ZNGA Zynga
$10.33 /

-0.39 (-3.64%)

Initiation
JD.com initiated with a Buy at Deutsche Bank » 18:58
01/25/21
01/25
18:58
01/25/21
18:58
JD

JD.com

$98.40 /

+3.49 (+3.68%)

Deutsche Bank analyst…

Deutsche Bank analyst Vitus Leung initiated coverage of JD.com with a Buy rating and $114 price target.

ShowHide Related Items >><<
JD JD.com
$98.40 /

+3.49 (+3.68%)

JD JD.com
$98.40 /

+3.49 (+3.68%)

09:52 Today
Fly Intel: Top five analyst initiations
06:15 Today Bernstein
JD.com initiated with an Outperform at Bernstein
01/14/21 Jefferies
JD Health initiated with a Buy at Jefferies
01/08/21 Mizuho
JD.com price target raised to $105 from $90 at Mizuho
JD JD.com
$98.40 /

+3.49 (+3.68%)

JD JD.com
$98.40 /

+3.49 (+3.68%)

JD JD.com
$98.40 /

+3.49 (+3.68%)

JD JD.com
$98.40 /

+3.49 (+3.68%)

Initiation
AppFolio initiated with an Underweight at Stephens » 18:57
01/25/21
01/25
18:57
01/25/21
18:57
APPF

AppFolio

$156.09 /

-0.29 (-0.19%)

Stephens analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APPF AppFolio
$156.09 /

-0.29 (-0.19%)

APPF AppFolio
$156.09 /

-0.29 (-0.19%)

16:24 Today Stephens
AppFolio initiated with an Underweight at Stephens
10/26/20 Keefe Bruyette
AppFolio initiated with a Market Perform at Keefe Bruyette
05/27/20 William Blair
William Blair downgrades AppFolio, sees greater odds of further deceleration
05/27/20 William Blair
AppFolio downgraded to Market Perform from Outperform at William Blair
APPF AppFolio
$156.09 /

-0.29 (-0.19%)

On The Fly
Fly Intel: After-Hours Movers » 18:53
01/25/21
01/25
18:53
01/25/21
18:53
IPAR

Inter Parfums

$60.50 /

+1.41 (+2.39%)

, GGG

Graco

$74.74 /

-1.17 (-1.54%)

, FUL

H.B. Fuller

$50.80 /

-1.98 (-3.75%)

, WSFS

WSFS Financial

$46.04 /

-0.5 (-1.07%)

, HXL

Hexcel

$47.09 /

-1.235 (-2.56%)

, STLD

Steel Dynamics

$38.37 /

-0.35 (-0.90%)

, BDGE

Bridge Bancorp

$27.19 /

-0.08 (-0.29%)

, STAA

Staar Surgical

$89.69 /

-1.69 (-1.85%)

, IAC

IAC

$202.84 /

+1.83 (+0.91%)

, NBTX

Nanobiotix

$17.47 /

-1.25 (-6.68%)

, BCRX

BioCryst

$9.15 /

-0.06 (-0.65%)

, JJSF

J & J Snack Foods

$156.47 /

+3.58 (+2.34%)

, CR

Crane

$78.60 /

-2.15 (-2.66%)

, KRMD

Koru Medical

$5.13 /

-0.06 (-1.16%)

, QUMU

Qumu

$8.11 /

-0.32 (-3.80%)

, SEEL

Seelos Therapeutics

$2.65 /

+0.07 (+2.71%)

, CVAC

CureVac

$104.31 /

+2.31 (+2.26%)

, ASO

Academy Sports

$23.70 /

+1.28 (+5.71%)

Check out this evening's…

ShowHide Related Items >><<
WSFS WSFS Financial
$46.04 /

-0.5 (-1.07%)

STLD Steel Dynamics
$38.37 /

-0.35 (-0.90%)

STAA Staar Surgical
$89.69 /

-1.69 (-1.85%)

SEEL Seelos Therapeutics
$2.65 /

+0.07 (+2.71%)

NBTX Nanobiotix
$17.47 /

-1.25 (-6.68%)

KRMD Koru Medical
$5.13 /

-0.06 (-1.16%)

JJSF J & J Snack Foods
$156.47 /

+3.58 (+2.34%)

IPAR Inter Parfums
$60.50 /

+1.41 (+2.39%)

IAC IAC
$202.84 /

+1.83 (+0.91%)

HXL Hexcel
$47.09 /

-1.235 (-2.56%)

GGG Graco
$74.74 /

-1.17 (-1.54%)

FUL H.B. Fuller
$50.80 /

-1.98 (-3.75%)

CVAC CureVac
$104.31 /

+2.31 (+2.26%)

CR Crane
$78.60 /

-2.15 (-2.66%)

BDGE Bridge Bancorp
$27.19 /

-0.08 (-0.29%)

BCRX BioCryst
$9.15 /

-0.06 (-0.65%)

ASO Academy Sports
$23.70 /

+1.28 (+5.71%)

IPAR Inter Parfums
$60.50 /

+1.41 (+2.39%)

12/02/20 DA Davidson
Inter Parfums price target lowered to $50 from $55 at DA Davidson
11/11/20 DA Davidson
Inter Parfums price target raised to $55 from $39 at DA Davidson
11/11/20 Citi
Inter Parfums price target raised to $56 from $46 at Citi
08/12/20 BWS Financial
Inter Parfums upgraded to Buy from Neutral at BWS Financial
GGG Graco
$74.74 /

-1.17 (-1.54%)

01/19/21 Jefferies
Graco upgraded to Buy from Hold at Jefferies
10/23/20 RBC Capital
Graco price target raised to $72 from $65 at RBC Capital
10/16/20 Berenberg
Graco initiated with a Hold at Berenberg
08/11/20
Fly Intel: Top five analyst upgrades
FUL H.B. Fuller
$50.80 /

-1.98 (-3.75%)

01/04/21 Baird
H.B. Fuller upgraded to Outperform, added to 2021 top picks at Baird
01/04/21 Baird
H.B. Fuller upgraded to Outperform from Neutral at Baird
12/18/20
Fly Intel: Top five analyst upgrades
12/18/20 Citi
H.B. Fuller upgraded to Buy from Neutral at Citi
WSFS WSFS Financial
$46.04 /

-0.5 (-1.07%)

04/01/20 Keefe Bruyette
WSFS Financial upgraded to Outperform from Market Perform at Keefe Bruyette
HXL Hexcel
$47.09 /

-1.235 (-2.56%)

01/21/21 Credit Suisse
Hexcel downgraded to Underperform from Neutral at Credit Suisse
01/21/21 Credit Suisse
Hexcel downgraded to Underperform from Neutral at Credit Suisse
12/15/20 KeyBanc
Hexcel downgraded to Sector Weight at KeyBanc
12/14/20 KeyBanc
Hexcel downgraded to Sector Weight from Overweight at KeyBanc
STLD Steel Dynamics
$38.37 /

-0.35 (-0.90%)

12/09/20 Morgan Stanley
Steel Dynamics initiated with an Overweight at Morgan Stanley
10/21/20 BMO Capital
Steel Dynamics price target raised to $35 from $32 at BMO Capital
09/18/20 BMO Capital
Steel Dynamics price target raised to $32 from $29 at BMO Capital
07/29/20 Deutsche Bank
Steel Dynamics price target raised to $31 from $27 at Deutsche Bank
BDGE Bridge Bancorp
$27.19 /

-0.08 (-0.29%)

12/16/20 Boenning & Scattergood
Bridge Bancorp downgraded to Neutral from Outperform at Boenning & Scattergood
11/13/20 DA Davidson
Bridge Bancorp upgraded to Buy from Neutral at DA Davidson
STAA Staar Surgical
$89.69 /

-1.69 (-1.85%)

01/19/21 Benchmark
Staar Surgical downgraded to Hold on valuation at Benchmark
01/19/21 Benchmark
Staar Surgical downgraded to Hold from Buy at Benchmark
11/09/20 Canaccord
Staar Surgical price target raised to $84 from $70 at Canaccord
10/26/20 Sidoti
Staar Surgical downgraded to Neutral from Buy at Sidoti
IAC IAC
$202.84 /

+1.83 (+0.91%)

18:12 Today Piper Sandler
IAC price target raised to $240 from $211 at Piper Sandler
01/14/21 Deutsche Bank
IAC price target raised to $230 from $165 at Deutsche Bank
01/12/21 Piper Sandler
IAC price target raised to $211 from $205 at Piper Sandler
01/08/21 Goldman Sachs
Goldman Sachs sees IAC news as positive for MGM Resorts
NBTX Nanobiotix
$17.47 /

-1.25 (-6.68%)

01/05/21 Evercore ISI
Nanobiotix initiated with an Outperform at Evercore ISI
01/05/21 UBS
Nanobiotix initiated with a Buy at UBS
BCRX BioCryst
$9.15 /

-0.06 (-0.65%)

12/22/20 JMP Securities
BioCryst selloff today a buying opportunity, says JMP Securities
12/07/20 H.C. Wainwright
BioCryst price target raised to $14 from $13 at H.C. Wainwright
12/04/20 Piper Sandler
BioCryst receives on-time approval with 'clean' label, says Piper Sandler
11/23/20 Evercore ISI
BioCryst initiated with an Outperform at Evercore ISI
JJSF J & J Snack Foods
$156.47 /

+3.58 (+2.34%)

05/12/20 CL King
J & J Snack Foods upgraded to Buy from Neutral at CL King
CR Crane
$78.60 /

-2.15 (-2.66%)

01/07/21 Vertical Research
Crane upgraded to Buy with $97 price target at Vertical Research
01/07/21 DA Davidson
Crane cut to Neutral at DA Davidson on valuation
01/07/21 DA Davidson
Crane downgraded to Neutral from Buy at DA Davidson
10/07/20 DA Davidson
DA Davidson positive on Crane's Engineered Materials, PMT segments
KRMD Koru Medical
$5.13 /

-0.06 (-1.16%)

18:49 Today Piper Sandler
Koru Medical downgraded to Neutral from Overweight at Piper Sandler
11/04/20 Piper Sandler
Koru Medical earnings selloff a buying opportunity, says Piper Sandler
08/10/20 H.C. Wainwright
KORU Medical Systems initiated with a Buy at H.C. Wainwright
08/05/20 Piper Sandler
KORU Medical Systems price target raised to $14 from $12 at Piper Sandler
QUMU Qumu
$8.11 /

-0.32 (-3.80%)

07/15/20 Craig-Hallum
Qumu price target raised to $5 from $4 at Craig-Hallum
06/30/20 Craig-Hallum
Qumu upgraded to Buy at Craig-Hallum after merger agreement termination
06/30/20 Craig-Hallum
Qumu upgraded to Buy from Hold at Craig-Hallum
02/12/20
Qumu downgraded to Neutral from Buy at Dougherty
SEEL Seelos Therapeutics
$2.65 /

+0.07 (+2.71%)

09/09/20 Roth Capital
Seelos Therapeutics shares 'substantially undervalued,' says Roth Capital
06/23/20 Roth Capital
Seelos Therapeutics price target raised to $12 from $8 Roth Capital
CVAC CureVac
$104.31 /

+2.31 (+2.26%)

01/07/21 Morgan Stanley
CureVac COVID-19 deal provides 'sentiment boost' for Bayer, says Morgan Stanley
12/10/20 Credit Suisse
CureVac downgraded to Underperform on rising valuation at Credit Suisse
12/10/20 Credit Suisse
CureVac downgraded to Underperform from Neutral at Credit Suisse
11/02/20 Piper Sandler
CureVac's positive vaccine data bodes well for Arcturus's ARCT-021, says Piper
ASO Academy Sports
$23.70 /

+1.28 (+5.71%)

10/27/20
Fly Intel: Top five analyst initiations
10/27/20 UBS
Academy Sports initiated with a Buy at UBS
10/27/20 Credit Suisse
Academy Sports initiated with an Outperform at Credit Suisse
10/27/20 JPMorgan
Academy Sports initiated with an Overweight at JPMorgan
WSFS WSFS Financial
$46.04 /

-0.5 (-1.07%)

STLD Steel Dynamics
$38.37 /

-0.35 (-0.90%)

STAA Staar Surgical
$89.69 /

-1.69 (-1.85%)

QUMU Qumu
$8.11 /

-0.32 (-3.80%)

KRMD Koru Medical
$5.13 /

-0.06 (-1.16%)

JJSF J & J Snack Foods
$156.47 /

+3.58 (+2.34%)

IPAR Inter Parfums
$60.50 /

+1.41 (+2.39%)

IAC IAC
$202.84 /

+1.83 (+0.91%)

HXL Hexcel
$47.09 /

-1.235 (-2.56%)

GGG Graco
$74.74 /

-1.17 (-1.54%)

FUL H.B. Fuller
$50.80 /

-1.98 (-3.75%)

CR Crane
$78.60 /

-2.15 (-2.66%)

BDGE Bridge Bancorp
$27.19 /

-0.08 (-0.29%)

BCRX BioCryst
$9.15 /

-0.06 (-0.65%)

ASO Academy Sports
$23.70 /

+1.28 (+5.71%)

  • 28
    Jan
  • 26
    Jan
  • 26
    Jan
  • 28
    Jan
  • 20
    Jan
  • 11
    Dec
  • 02
    Oct
  • 14
    Aug
  • 19
    Jun
  • 28
    May
  • 12
    Mar
  • 11
    Feb
STLD Steel Dynamics
$38.37 /

-0.35 (-0.90%)

IAC IAC
$202.84 /

+1.83 (+0.91%)

HXL Hexcel
$47.09 /

-1.235 (-2.56%)

CVAC CureVac
$104.31 /

+2.31 (+2.26%)

QUMU Qumu
$8.11 /

-0.32 (-3.80%)

KRMD Koru Medical
$5.13 /

-0.06 (-1.16%)

IPAR Inter Parfums
$60.50 /

+1.41 (+2.39%)

IAC IAC
$202.84 /

+1.83 (+0.91%)

HXL Hexcel
$47.09 /

-1.235 (-2.56%)

FUL H.B. Fuller
$50.80 /

-1.98 (-3.75%)

CVAC CureVac
$104.31 /

+2.31 (+2.26%)

BCRX BioCryst
$9.15 /

-0.06 (-0.65%)

ASO Academy Sports
$23.70 /

+1.28 (+5.71%)

STLD Steel Dynamics
$38.37 /

-0.35 (-0.90%)

KRMD Koru Medical
$5.13 /

-0.06 (-1.16%)

FUL H.B. Fuller
$50.80 /

-1.98 (-3.75%)

CVAC CureVac
$104.31 /

+2.31 (+2.26%)

BCRX BioCryst
$9.15 /

-0.06 (-0.65%)

ASO Academy Sports
$23.70 /

+1.28 (+5.71%)

Downgrade
Koru Medical downgraded to Neutral from Overweight at Piper Sandler » 18:49
01/25/21
01/25
18:49
01/25/21
18:49
KRMD

Koru Medical

$5.13 /

-0.06 (-1.16%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KRMD Koru Medical
$5.13 /

-0.06 (-1.16%)

KRMD Koru Medical
$5.13 /

-0.06 (-1.16%)

11/04/20 Piper Sandler
Koru Medical earnings selloff a buying opportunity, says Piper Sandler
08/10/20 H.C. Wainwright
KORU Medical Systems initiated with a Buy at H.C. Wainwright
08/05/20 Piper Sandler
KORU Medical Systems price target raised to $14 from $12 at Piper Sandler
07/16/20 Canaccord
KORU Medical Systems initiated with a Buy at Canaccord
KRMD Koru Medical
$5.13 /

-0.06 (-1.16%)

  • 19
    Jun
KRMD Koru Medical
$5.13 /

-0.06 (-1.16%)

KRMD Koru Medical
$5.13 /

-0.06 (-1.16%)

Earnings
Southern Copper reports Q4 EPS 76c, consensus 70c » 18:40
01/25/21
01/25
18:40
01/25/21
18:40
SCCO

Southern Copper

$69.75 /

-1.42 (-2.00%)

Reports Q4 revenue…

Reports Q4 revenue $2.35B, consensus $2.08B. Mr. German Larrea, Chairman of the Board, commenting on the company's progress and current circumstances said: "Thanks to timely implementation of a well-designed COVID-19 protocol, strict hygiene and safety measures are firmly in place at all of our operations. This, coupled with the isolated nature of our physical mining operations and low-density workforce have helped us weather the pandemic. In this context, our units registered high economic contributions that led us to close the year with production records for copper, molybdenum and silver. We produced more than one million tons of our main product, copper, at a very competitive operating cash cost of $0.69 per pound, which attests to the strength of our operating position. The year 2021 began with news of better things to come: several COVID-19 vaccines have been approved and are being rolled out around the globe. We trust that this marks the beginning of the end of the CO ID-19 sanitary crisis. We believe this will open the door to significant economic recovery and drive an uptick in 2021 copper consumption. Accordingly, we believe the copper market will evolve positively, sustained by growth in consumption in China and in other economies."

ShowHide Related Items >><<
SCCO Southern Copper
$69.75 /

-1.42 (-2.00%)

SCCO Southern Copper
$69.75 /

-1.42 (-2.00%)

01/06/21 Barclays
Southern Copper initiated with an Underweight at Barclays
12/09/20 UBS
Southern Copper cut to Neutral at UBS after 39% year-to-date rally
12/09/20 UBS
Southern Copper downgraded to Neutral from Buy at UBS
12/01/20 HSBC
Southern Copper downgraded to Reduce from Hold at HSBC
Earnings
Great Southern Bancorp reports preliminary Q4 EPS $1.28, consensus 98c » 18:38
01/25/21
01/25
18:38
01/25/21
18:38
GSBC

Great Southern Bancorp

$50.42 /

-0.77 (-1.50%)

Reports preliminary Q4…

Reports preliminary Q4 NII $44.58M, consensus $43.88M. Q4 loan loss provision was $1.5M vs. $650K a year ago. Reports Q4 net charge-offs $762K. Book value per share was $45.79 at quarter end vs. $42.29 at previous quarter end. CEO Joseph Turner commented, "We ended a challenging year with strong operating results in Q4. (...) With the recent passage of the Economic Aid Act, we are pleased to participate in the reopening of the Small Business Administration's PPP lending program that provides emergency financial support through federally guaranteed loans for eligible small business customers. For Q4, the company earned $17.8M or $1.28 per diluted common share, vs. $17.9M or $1.24 per diluted common share for the same period in 2019. The earnings per share increase reflects thecCompany's common stock repurchase activities during 2020, with approximately 530,000 shares repurchased at an average price of $41.71".

ShowHide Related Items >><<
GSBC Great Southern Bancorp
$50.42 /

-0.77 (-1.50%)

12/17/20 Piper Sandler
Great Southern Bancorp upgraded to Overweight from Neutral at Piper Sandler
GSBC Great Southern Bancorp
$50.42 /

-0.77 (-1.50%)

Periodicals
Janet Yellen confirmed as U.S. Treasury Secretary, NY Times reports » 18:29
01/25/21
01/25
18:29
01/25/21
18:29
SPX

S&P 500

$0.00 /

+ (+0.00%)

, SPY

SPDR S&P 500 ETF Trust

$384.40 /

+1.55 (+0.40%)

The U.S. Senate has…

The U.S. Senate has confirmed former Federal Reserve chair Janet L. Yellen as the next U.S. Treasury Secretary, the New York Times' Alan Rappeport reports. Yellen was confirmed to the role by a 84-15 vote in the Senate, making her the first woman to be in the role in its 232-year history, the author notes. Reference Link

ShowHide Related Items >><<
SPX S&P 500
$0.00 /

+ (+0.00%)

SPX S&P 500
$0.00 /

+ (+0.00%)

01/07/21 Credit Suisse
Credit Suisse raises 2021 S&P 500 target to 4,200, sees 12% upside
11/09/20 JPMorgan
JPMorgan sees S&P 500 hitting 4,000 by early next year
09/01/20
Fed's Brainard says monetary policy to pivot from stabilization to accommodation
08/17/20 Goldman Sachs
Goldman boosts end of 2020 S&P 500 target to 3,600 from 3,000
SPY SPDR S&P 500 ETF Trust
$384.40 /

+1.55 (+0.40%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$384.40 /

+1.55 (+0.40%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$384.40 /

+1.55 (+0.40%)

SPX S&P 500
$0.00 /

+ (+0.00%)

Hot Stocks
Boot Barn CEO: Underlying business continues to be very strong » 18:24
01/25/21
01/25
18:24
01/25/21
18:24
BOOT

Boot Barn

$59.77 /

+1.4 (+2.40%)

In an interview on…

In an interview on CNBC's Mad Money, Jim Conroy said many of Boot Barn's internal initiatives are really taking hold. Mom & Pop stores are the company's main competition and it has been taking share from them, Conroy noted. It has been opening stores in mature markets and is not seeing cannibalization. Stores pay back in less than three years, Conroy said. "We're bullish on increasing our store count. A 500 store count is very much in reach," he added.

ShowHide Related Items >><<
BOOT Boot Barn
$59.77 /

+1.4 (+2.40%)

BOOT Boot Barn
$59.77 /

+1.4 (+2.40%)

01/22/21 Williams Capital
Boot Barn initiated with a Buy at Williams Trading
01/14/21 JPMorgan
Boot Barn price target raised to $63 from $60 at JPMorgan
01/12/21 Cowen
Boot Barn price target raised to $65 from $47 at Cowen
01/11/21 Craig-Hallum
Boot Barn price target raised to $48 from $34 at Craig-Hallum
BOOT Boot Barn
$59.77 /

+1.4 (+2.40%)

BOOT Boot Barn
$59.77 /

+1.4 (+2.40%)

BOOT Boot Barn
$59.77 /

+1.4 (+2.40%)

Hot Stocks
German American Bancorp board authorizes new 1M share buyback » 18:19
01/25/21
01/25
18:19
01/25/21
18:19
GABC

German American Bancorp

$33.27 /

-1.22 (-3.54%)

The company…

The company "announced that its Board has approved a new share repurchase plan authorizing the repurchase of one million shares, or approximately 4% of the company's total common shares outstanding. Stock repurchases are expected to be made from time to time on the open market or in privately negotiated transactions, subject to applicable securities law. The new plan, which replaces a similar plan approved in January 2020 that had repurchase authority for 778,088 shares remaining, does not obligate the company to repurchase any specific dollar amount or number of shares."

ShowHide Related Items >><<
GABC German American Bancorp
$33.27 /

-1.22 (-3.54%)

GABC German American Bancorp
$33.27 /

-1.22 (-3.54%)

Hot Stocks
German American Bancorp raises quarterly dividend to 21c from 19c per share » 18:18
01/25/21
01/25
18:18
01/25/21
18:18
GABC

German American Bancorp

$33.27 /

-1.22 (-3.54%)

The dividend will be…

The dividend will be payable on February 20, 2021 to shareholders of record as of February 10, 2021.

ShowHide Related Items >><<
GABC German American Bancorp
$33.27 /

-1.22 (-3.54%)

GABC German American Bancorp
$33.27 /

-1.22 (-3.54%)

Earnings
German American Bancorp reports Q4 EPS 79c, consensus 58c » 18:17
01/25/21
01/25
18:17
01/25/21
18:17
GABC

German American Bancorp

$33.27 /

-1.22 (-3.54%)

Reports Q4 revenue…

Reports Q4 revenue $56.8M, consensus $51.93M. Reports Q4 provision for credit losses of $2.0M vs. $1.6M last year and net interest margin 3.71% vs. 4.02% last year. Mark A. Schroeder, CEO, stated, "In the face of all the challenges experienced in 2020 around the COVID-19 pandemic, we are extremely pleased to have been able to post record earnings for both the fourth quarter and for fiscal year 2020. It is only because of the extraordinary efforts of our team of talented financial professionals and the loyalty of our clients, located throughout our footprint in Indiana and Kentucky, that our Company was able to achieve this amazing record of 11 consecutive years of annual record earnings performance and 16 consecutive years of delivering a double digit annual return on shareholders' equity. Very few banking organizations in the country can match this level of consistent, long-term profitability."

ShowHide Related Items >><<
GABC German American Bancorp
$33.27 /

-1.22 (-3.54%)

GABC German American Bancorp
$33.27 /

-1.22 (-3.54%)

Recommendations
IAC price target raised to $240 from $211 at Piper Sandler » 18:12
01/25/21
01/25
18:12
01/25/21
18:12
IAC

IAC

$202.84 /

+1.83 (+0.91%)

Piper Sandler analyst…

Piper Sandler analyst Thomas Champion raised the firm's price target on IAC to $240 from $211 and keeps an Overweight rating on the shares after the company announced an additional $300M in external funding for Vimeo, roughly doubling the valuation since the external funding was first announced several months ago. The move takes Vimeo one step close to a spin later in 2021, Champion said.

ShowHide Related Items >><<
IAC IAC
$202.84 /

+1.83 (+0.91%)

IAC IAC
$202.84 /

+1.83 (+0.91%)

01/14/21 Deutsche Bank
IAC price target raised to $230 from $165 at Deutsche Bank
01/12/21 Piper Sandler
IAC price target raised to $211 from $205 at Piper Sandler
01/08/21 Goldman Sachs
Goldman Sachs sees IAC news as positive for MGM Resorts
12/23/20
Fly Intel: Top five analyst calls
IAC IAC
$202.84 /

+1.83 (+0.91%)

IAC IAC
$202.84 /

+1.83 (+0.91%)

IAC IAC
$202.84 /

+1.83 (+0.91%)

Syndicate
EZGO Technologies 2.8M share IPO priced at $4.00  18:06
01/25/21
01/25
18:06
01/25/21
18:06
EZGO

EZGO Technologies

$0.00 /

+ (+0.00%)

 
Downgrade
Tenaris downgraded to Neutral from Buy at Goldman Sachs » 17:49
01/25/21
01/25
17:49
01/25/21
17:49
TS

Tenaris

$15.27 /

-0.345 (-2.21%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TS Tenaris
$15.27 /

-0.345 (-2.21%)

TS Tenaris
$15.27 /

-0.345 (-2.21%)

01/11/21 Barclays
Tenaris price target raised to EUR 5.90 from EUR 5.30 at Barclays
11/24/20 BofA
Tenaris upgraded to Buy from Neutral at BofA
11/20/20 Stifel
Tenaris downgraded to Hold on limited upside post rally at Stifel
11/20/20 Stifel
Tenaris downgraded to Hold from Buy at Stifel
TS Tenaris
$15.27 /

-0.345 (-2.21%)

Earnings
Equity Bancshares reports Q4 EPS 84c, consensus 54c » 17:41
01/25/21
01/25
17:41
01/25/21
17:41
EQBK

Equity Bancshares

$23.03 /

-0.37 (-1.58%)

Reports Q4 revenue…

Reports Q4 revenue $44.1M, consensus $38.18M. The company states: "Q4 net interest margin increased 41 basis points to 3.88% for the three months ended December 31, 2020 from 3.47% for the three months ended September 30, 2020. The provision for loan losses was $1.0M for the three months ended December 31, 2020, as compared to $815K for the three months ended September 30, 2020. For the three months ended December 31, 2020, we had net charge-offs of $1.4M as compared to $806K for three months ended September 30, 2020."

ShowHide Related Items >><<
EQBK Equity Bancshares
$23.03 /

-0.37 (-1.58%)

EQBK Equity Bancshares
$23.03 /

-0.37 (-1.58%)

07/16/20 DA Davidson
Equity Bancshares downgraded to Neutral from Buy at DA Davidson
07/16/20 DA Davidson
Equity Bancshares downgraded to Neutral from Buy at DA Davidson
EQBK Equity Bancshares
$23.03 /

-0.37 (-1.58%)

Hot Stocks
Apple names hardware chief Dan Riccio to lead 'new project' » 17:40
01/25/21
01/25
17:40
01/25/21
17:40
AAPL

Apple

$142.88 /

+3.93 (+2.83%)

Apple announced Dan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AAPL Apple
$142.88 /

+3.93 (+2.83%)

AAPL Apple
$142.88 /

+3.93 (+2.83%)

08:44 Today Morgan Stanley
Morgan Stanley says market closer to recognizing Alphabet sum-of-the-parts value
08:27 Today Evercore ISI
Evercore ISI raises Apple price target to $160, sees higher odds of car product
07:33 Today Raymond James
Apple price target raised to $150 from $140 at Raymond James
07:19 Today JPMorgan
JPMorgan sees 'large beat' from Apple, keeps $150 price target
AAPL Apple
$142.88 /

+3.93 (+2.83%)

AAPL Apple
$142.88 /

+3.93 (+2.83%)

AAPL Apple
$142.88 /

+3.93 (+2.83%)

AAPL Apple
$142.88 /

+3.93 (+2.83%)

Earnings
Equity Bancshares reports Q4 EPS 84c, consensus 54c » 17:40
01/25/21
01/25
17:40
01/25/21
17:40
EQBK

Equity Bancshares

$23.03 /

-0.37 (-1.58%)

Reports Q4 tangible book…

Reports Q4 tangible book value per share $24.32. Reports Q4 CET1 capital ratio 12.82%. "No one could have imagined the challenges that our employees, customers and communities faced in 2020 due to the pandemic. The perseverance exhibited in collaborating with our customers through a period of great uncertainty showed the integrity, entrepreneurship and accountability of the Equity team. I am honored to be a part of a team that worked tirelessly for customers when they needed us, and in turn, our customers were able to support our communities in a time of need," said Brad Elliott, chairman and CEO of Equity.

ShowHide Related Items >><<
EQBK Equity Bancshares
$23.03 /

-0.37 (-1.58%)

EQBK Equity Bancshares
$23.03 /

-0.37 (-1.58%)

07/16/20 DA Davidson
Equity Bancshares downgraded to Neutral from Buy at DA Davidson
07/16/20 DA Davidson
Equity Bancshares downgraded to Neutral from Buy at DA Davidson
EQBK Equity Bancshares
$23.03 /

-0.37 (-1.58%)

Hot Stocks
Minnesota DOH reports first U.S. case of COVID-19 variant first found in Brazil » 17:37
01/25/21
01/25
17:37
01/25/21
17:37
SPX

S&P 500

$0.00 /

+ (+0.00%)

, SPY

SPDR S&P 500 ETF Trust

$384.40 /

+1.55 (+0.40%)

, PFE

Pfizer

$37.28 /

+0.74 (+2.03%)

, BNTX

BioNTech

$110.62 /

+2.33 (+2.15%)

, MRNA

Moderna

$147.00 /

+15.95 (+12.17%)

, AZN

AstraZeneca

$54.02 /

+0.76 (+1.43%)

, JNJ

Johnson & Johnson

$165.91 /

+2.23 (+1.36%)

, NVAX

Novavax

$131.47 /

+4.48 (+3.53%)

The Minnesota Department…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPX S&P 500
$0.00 /

+ (+0.00%)

PFE Pfizer
$37.28 /

+0.74 (+2.03%)

NVAX Novavax
$131.47 /

+4.48 (+3.53%)

MRNA Moderna
$147.00 /

+15.95 (+12.17%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

BNTX BioNTech
$110.62 /

+2.33 (+2.15%)

AZN AstraZeneca
$54.02 /

+0.76 (+1.43%)

SPX S&P 500
$0.00 /

+ (+0.00%)

01/07/21 Credit Suisse
Credit Suisse raises 2021 S&P 500 target to 4,200, sees 12% upside
11/09/20 JPMorgan
JPMorgan sees S&P 500 hitting 4,000 by early next year
09/01/20
Fed's Brainard says monetary policy to pivot from stabilization to accommodation
08/17/20 Goldman Sachs
Goldman boosts end of 2020 S&P 500 target to 3,600 from 3,000
SPY SPDR S&P 500 ETF Trust
$384.40 /

+1.55 (+0.40%)

PFE Pfizer
$37.28 /

+0.74 (+2.03%)

01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
01/14/21 Oppenheimer
Essa Pharma price target raised to $20 from $9 at Oppenheimer
01/05/21 Argus
Viatris initiated with a Hold at Argus
12/31/20 Ladenburg
UK study supports potential of Arcturus COVID vaccine candidate, says Ladenburg
BNTX BioNTech
$110.62 /

+2.33 (+2.15%)

12/29/20 Citi
Arcturus selloff brings 'very good' buying opportunity, says Citi
12/22/20 Roth Capital
Translate Bio price target raised to $37 from $30 at Roth Capital
12/15/20 Jefferies
Jefferies starts Maravai at Buy, says 'more than just a COVID vaccine play'
MRNA Moderna
$147.00 /

+15.95 (+12.17%)

09:47 Today Piper Sandler
Piper reiterates $170 target on Moderna with vaccine active on new strains
01/06/21 Piper Sandler
Moderna price target raised to $170 after EU vaccine approval at Piper Sandler
01/04/21 Piper Sandler
Moderna shares warrant 'fresh look' after 41% pullback, says Piper Sandler
AZN AstraZeneca
$54.02 /

+0.76 (+1.43%)

01/22/21 Barclays
AstraZeneca price target lowered to 9,000 GBp from 9,300 GBp at Barclays
01/19/21 BTIG
Adaptive Biotechnologies price target raised to $74 from $66 at BTIG
01/15/21 Berenberg
AstraZeneca price target lowered to 10,000 GBp from 10,500 GBp at Berenberg
01/15/21
Fly Intel: Top five analyst initiations
JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

01/15/21 B. Riley Securities
Arcturus Therapeutics downgraded to Neutral from Buy at B. Riley Securities
12/29/20 Piper Sandler
Piper still believes in Arcturus vaccine after 'underwhelming' immunogenicity
NVAX Novavax
$131.47 /

+4.48 (+3.53%)

12/29/20 B. Riley Securities
Novavax selloff yesterday brings 'compelling' opportunity, says B. Riley
12/28/20 JPMorgan
JPMorgan sees data from Novavax vaccine trial in U.S. in March/April
12/14/20 Jefferies
Novavax initiated with a Buy at Jefferies
12/07/20 B. Riley Securities
Arcturus Therapeutics price target raised to $111 from $64 at B. Riley
PFE Pfizer
$37.28 /

+0.74 (+2.03%)

NVAX Novavax
$131.47 /

+4.48 (+3.53%)

MRNA Moderna
$147.00 /

+15.95 (+12.17%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

BNTX BioNTech
$110.62 /

+2.33 (+2.15%)

AZN AstraZeneca
$54.02 /

+0.76 (+1.43%)

  • 23
    Jul
  • 19
    May
  • 12
    Feb
  • 06
    Feb
SPX S&P 500
$0.00 /

+ (+0.00%)

PFE Pfizer
$37.28 /

+0.74 (+2.03%)

NVAX Novavax
$131.47 /

+4.48 (+3.53%)

MRNA Moderna
$147.00 /

+15.95 (+12.17%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

BNTX BioNTech
$110.62 /

+2.33 (+2.15%)

AZN AstraZeneca
$54.02 /

+0.76 (+1.43%)

PFE Pfizer
$37.28 /

+0.74 (+2.03%)

NVAX Novavax
$131.47 /

+4.48 (+3.53%)

MRNA Moderna
$147.00 /

+15.95 (+12.17%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

BNTX BioNTech
$110.62 /

+2.33 (+2.15%)

AZN AstraZeneca
$54.02 /

+0.76 (+1.43%)

SPY SPDR S&P 500 ETF Trust
$384.40 /

+1.55 (+0.40%)

SPX S&P 500
$0.00 /

+ (+0.00%)

PFE Pfizer
$37.28 /

+0.74 (+2.03%)

NVAX Novavax
$131.47 /

+4.48 (+3.53%)

MRNA Moderna
$147.00 /

+15.95 (+12.17%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

BNTX BioNTech
$110.62 /

+2.33 (+2.15%)

AZN AstraZeneca
$54.02 /

+0.76 (+1.43%)

SPY SPDR S&P 500 ETF Trust
$384.40 /

+1.55 (+0.40%)

SPX S&P 500
$0.00 /

+ (+0.00%)

Conference/Events
Apellis to hold a conference call » 17:35
01/25/21
01/25
17:35
01/25/21
17:35
APLS

Apellis

$46.30 /

+0.68 (+1.49%)

Management holds a…

Management holds a conference call to discuss Pegcetacoplan: advancing the first potential treatment for Geographic Atrophy (GA) on January 28 at 10 am. Webcast Link

ShowHide Related Items >><<
APLS Apellis
$46.30 /

+0.68 (+1.49%)

APLS Apellis
$46.30 /

+0.68 (+1.49%)

12/14/20 Roth Capital
Apellis price target raised to $73 from $50 at Roth Capital
12/10/20 Cowen
Apellis price target raised to $55 from $45 at Cowen
12/04/20 JPMorgan
Apellis price target raised to $87 from $50 at JPMorgan
12/01/20 BMO Capital
Apellis price target raised to $66 from $57 at BMO Capital
APLS Apellis
$46.30 /

+0.68 (+1.49%)

APLS Apellis
$46.30 /

+0.68 (+1.49%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.